Advertisement

Immunologic Research

, 13:1 | Cite as

Suppressin: An endogenous negative regulator of immune cell activation

  • Elisabeth M. H. Ban
  • Robert D. LeBoeuf
Article

Abstract

We have recently identified a new suppressor molecule we named suppressin (SPN) that has all the characteristics of a global negative regulator of the immune system. SPN is a unique 63-kD monomeric polypeptide with a pI of 8.1 that is produced and secreted under basal conditions by murine splenocytes, human peripheral mononuclear cells, and hormone-secreting pituitary cells. The biological actions of SPN in vitro include the inhibition of mitogen-induced proliferation and immunoglobulin synthesis of lymphocytes and the suppression of interleukin-2-dependent CTLL-2 cell proliferation. In addition, SPN enhances natural killer cell activity by eliciting interferon-α and-β synthesis and secretion. SPN effects are reversible, nontoxic, and require the continuous presence of exogenous SPN. T lymphocytes stimulated with concanavalin A or phytohemagglutinin are more sensitive to SPN (90% inhibition) than are lipopolysaccharide-stimulated B cells (60% inhibition). SPN arrests lymphocytes in the G0/G1 phase of the cell cycle after reduction of their RNA, protein and DNA synthesis, suggesting that SPN inhibits the processes required for G0 transition to G1. SPN is found intracellularly in all unstimulated lymphocyte subsets, monocytes, and in phytohemagglutinin-activated T lymphocytes immunopositive for the low affinity interleukin-2 receptor. These results suggest that SPN may be a major negative regulator of cell proliferation in the immune system. All SPN-producing cell types are also sensitive to SPN. Collectively, the results of these experiments provide the foundations for a model in which SPN regulates lymphocyte proliferation in an autocrine and/or paracrine manner. Additional evidence supporting this hypothesis was provided by experiments showing that by blocking endogenous SPN activity in vitro with neutralizing anti-SPN antibodies unstimulated lymphocyte proliferation is induced. Lastly, SPN also inhibits the proliferation of leukemia and lymphoma cells in vitro, suggesting a potential role for SPN in regulating tumor cell proliferation.

Key Words

Negative regulator Lymphocyte Antiproliferative Antitumoral Suppressor molecule 

References

  1. 1.
    Sporn MB, Roberts AB, Shull JH, Smith JM, Ward JM, Sodek J: Polypeptide transforming growth factors isolated from bovine sources and used for wound healing in vivo. Science 1983;219:1329–1331.PubMedCrossRefGoogle Scholar
  2. 2.
    Massagué J: Type β transforming growth factor from feline sarcoma virus-transformed rat cells. J Biol Chem 1984;259:9756–9761.PubMedGoogle Scholar
  3. 3.
    Hard C, Röllinghoff M, Pfizenmaier K, Mosmann H, Wagner H: Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo. J Exp Med 1981;154:262–274.CrossRefGoogle Scholar
  4. 4.
    Playfair JHL, Dockrell HM, Lelchuk R: The importance of being nearest. Immunol Today 1984;5:38–39.CrossRefGoogle Scholar
  5. 5.
    Asherson GL, Colizzi V, Zembala M: An overview of T-suppressor cell circuits. Annu Rev Immunol 1986; 4:37–68.PubMedCrossRefGoogle Scholar
  6. 6.
    Maier T, Holda JH, Claman HN: Natural suppressor (NS) cells. Immunol Today 1986;10:312–315.CrossRefGoogle Scholar
  7. 7.
    Almawi WY, Dolphin PJ, Thies RL, McMaster R, Levy JG, Pope BL: Suppressor cell-inducing factor: A new lymphokine secreted by a natural suppressor cell line with natural cytotoxic activity. J Immunol 1988; 141:2529–2535.PubMedGoogle Scholar
  8. 8.
    Tadakuma T, Pierce CW: Site of action of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells. J Immunol 1976;117:967–972.PubMedGoogle Scholar
  9. 9.
    Chiba K, Nishimura T, Hashimoto Y: Stimulated rat T cell-derived factor for cellular DNA synthesis (STIF). J Immunol 1985;134:1019–1025.PubMedGoogle Scholar
  10. 10.
    Namba Y, Jegasothy BV, Walksman BH: Regulatory substances produced by lymphocytes: Production of inhibitor of DNA synthesis (IDS) by proliferating T lymphocytes. J Immunol 1977;118:1379–1384.PubMedGoogle Scholar
  11. 11.
    Greene WC, Fleisher TA, Waldman TA: Soluble suppressor supermatants elaborated by concanavalin A-activated human mononuclear cells: I. Characterization of soluble suppressor of T-cell proliferation. J Immunol 1981;126:1185–1191.PubMedGoogle Scholar
  12. 12.
    Cavalieri RL, Havell EA, Vilček J, Pestka S: Induction and decay of human fibroblast interferon mRNA. Proc Natl Acad Sci USA 1977;74:4415–4419.PubMedCrossRefGoogle Scholar
  13. 13.
    Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS: Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986;163:1037–1050.PubMedCrossRefGoogle Scholar
  14. 14.
    Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B: Some recent advances in the chemistry and biology of transforming growth factor-β. J Cell Biol 1987;105:1039–1045.PubMedCrossRefGoogle Scholar
  15. 15.
    LeBoeuf RD, Burns JN, Bost KL, Blalock JE: Isolation, purification and partial characterization of suppressin, a novel inhibitor of cell proliferation. J Biol Chem 1990;265:158–165.PubMedGoogle Scholar
  16. 16.
    LeBoeuf RD, Carr DJJ, Green MM, Blalock JE: Cellular effects of suppressin, a biological response modifier of cells of the immune systems. Proc Neuro Endocrin Immunology 1990;3:176–187.Google Scholar
  17. 17.
    LeBoeuf RD: Suppressin: A novel negative regulator of cell proliferation: Pituitary production and its effects on endocrine cells. Trends Endocrin Metab 1994; in press.Google Scholar
  18. 18.
    Ban EM, Propst SM, Blalock JE, LeBoeuf RD: Identification of suppressin producing cells in the rat pituitary. Endocrinology 1993;133:241–247.PubMedCrossRefGoogle Scholar
  19. 19.
    Pestka S, Langer JA, Zoon KC, Samuel CE: Interferons and their actions. Annu Rev Biochem 1987;56:727–777.PubMedCrossRefGoogle Scholar
  20. 20.
    Assoin RK, Komoriya A, Meyers CA, Miller DM, Sporn MB: Transforming growth factor-beta in human platelets. J Biol Chem 1983; 258:7155–7160.Google Scholar
  21. 21.
    Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 1990;6:597–641.PubMedCrossRefGoogle Scholar
  22. 22.
    Bridgen PJ, Anfinsen CB, Corley L, Bose S, Zoon KC, Reugg UT, Buckler CE: Human lymphoblastoid interferon: Large scale production and partial purification. J Biol Chem 1977;252:6585–6587.PubMedGoogle Scholar
  23. 23.
    Wilkins JA, Sigurdson SL, Rutherford WJ: The production of immunoregulatory factors by human macrophage-like cell line: I. Characterization of an inhibitor of lymphocyte DNA synthesis. Cell Immunol 1983;75:328–336.PubMedCrossRefGoogle Scholar
  24. 24.
    Telerman A, Merluzzi WJ, Calvelli TA, Kunicka JE, Platsoucas CD: Hybridoma-derived human suppressor factors: Differential effects on mouse lymphocytes. Hybridoma 1989;8:25–36.PubMedCrossRefGoogle Scholar
  25. 25.
    Asai K, Hirano T, Kaneko S, Moriyama A, Nakanishi K, Isobe I, Eksioglu YZ, Kato T: A novel glial growth inhibitory factor, gliostatin, derived from neurofibroma. J Neurochem 1992;59:307–317.PubMedCrossRefGoogle Scholar
  26. 26.
    De Groote D, Zangerle PF, Gevaert Y, Fassote MF, Beguin Y, Noizat-Pirenne J, Gathy R, Lopez M, Dehart I, Igot D, Baudrihaye M, Delacroix D, Franchimont P: Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, INF-γ and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine 1992;4:239–248.PubMedCrossRefGoogle Scholar
  27. 27.
    Carr DJJ, Blalock JE, Green MM, LeBoeuf RD: Immunomodulatory characteristics of suppressin, a novel biological response modifier. J Neuroimmunol 1990;30:179–187.PubMedCrossRefGoogle Scholar
  28. 28.
    LeBoeuf RD, Blalock JE: Biochemical and cellular characteristics of suppressin, a novel pituitary-derived inhibitor of neuroendocrine and immune cell proliferation. Ann N Y Acad Sci 1990;594:393–395.CrossRefGoogle Scholar
  29. 29.
    Chang HL, Gillett N, Figari I, Lopez AR, Palladino MA, Derynck R: Increased transforming growth factor β expression inhibits cell proliferation in vitro, yet increases tumorigenicity and tumor growth of Meth A sarcoma cells. Cancer Res 1993;53:4391–4398.PubMedGoogle Scholar

Copyright information

© Humana Press Inc. 1995

Authors and Affiliations

  • Elisabeth M. H. Ban
    • 1
  • Robert D. LeBoeuf
    • 1
  1. 1.Department of Physiology and Biophysics BHSB 850University of Alabama at BirminghamBirmingham(USA)

Personalised recommendations